The Tyr-kinase inhibitor AG879, that blocks the ETK-PAK1 interaction, suppresses the RAS-induced PAK1 activation and malignant transformation
- Hong He
- , Yumiko Hirokawa
- , Aviv Gazit
- , Yoshihiro Yamashita
- , Hiroyuki Mano
- , Yuko Kawakami
- , Kawakami
- , Ching Yi Hsieh
- , Hsing Jien Kung
- , Guillaume Lessene
- , Jonathan Baell
- , Alexander Levitzki
- , Hiroshi Maruta*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
37
Scopus
citations